- Summits
- Sponsorship
- Retreats
- Media Opportunities
- News
- About
What begins as a conversation on stage can sometimes evolve into something far bigger.
For M. Walid Qoronfleh, Co-founder and Managing Director, Q3 Consulting Group (Q3CG), his participation in and leading the panel “Precision Medicine in MedTech: Shaping the Future of Personalised Care” at MedTech World Europe | Malta 2025 became the foundation for a newly published scholarly paper exploring one of healthcare’s most important frontiers: the future of personalised medical devices.
Recently published in Health and Technology, the paper, Precision medicine in medical technology-medtech: the future of healthcare through personalised devices, builds on the concept note he first introduced during the MedTech World summit to propose the panel discussion and has already received strong recognition during peer review for its novelty and forward-looking vision.
At its core, the paper explores how precision medicine is reshaping healthcare by moving beyond population-average decisions and toward individualised prevention, diagnosis and therapy.
“Precision medicine represents a transformative shift in healthcare from population-average decisions to individualised prevention, diagnosis and therapy,” Walid shared.
Rather than relying on a one-size-fits-all approach, the framework draws on each patient’s biological, environmental and lifestyle data to support more targeted clinical decisions. Walid argues that this same principle must now be applied to MedTech.
This vision is brought to life through the concept of personalised/precision medical devices (PMD™) — devices that generate patient-specific data, adapt interventions in real time and support better long-term health management.
For clinicians, innovators and healthcare systems, the implications are significant.
The framework spans a wide spectrum of technologies, from biosensors and wearables to implantables, companion diagnostics, drug delivery systems and digital therapeutics. More importantly, it offers a practical roadmap for integrating these solutions into everyday care pathways while improving outcomes, efficiency and equity.
Walid noted that the publication addresses what he sees as a major gap in the sector: the need to move from mass-produced medical devices toward solutions that reflect a subgroup or the individual patient.
“One key impact that this published paper will lead to is the understanding that patients who use MedTech devices can be stratified and that medical devices can be tailored or personalised.”
Walid described the MedTech World summit as a critical testing ground for the concept, helping refine the framework through dialogue with experts from across the MedTech ecosystem.
“The MedTech session has been helpful in many ways as a testing ground for the concept, refining our thinking and bringing focus to the personalised devices discussion.”
The panel discussions, audience questions and networking opportunities all contributed to sharpening the final direction of the manuscript.
By bringing together voices from engineering, regulatory, insurance and clinical practice, the event created the kind of multidisciplinary environment needed for an idea of this scale to mature into publishable research.
“Summits like MedTech World are extremely important as a platform,” Walid said. “They are truly a place for novel ideas exchange, reality check examination and promote engagement.”
He added that the diversity of thought leaders and stakeholders of attendees have helped deepen the understanding of the challenges, opportunities and system-wide implications surrounding personalised devices.
This role, moving ideas from thought leadership into industry action, is central to what MedTech World continues to foster across its global events.
The impact of the publication is already extending beyond the paper itself.
Following both the panel discussion and publication, new research collaborations are emerging, and work is now underway on a second paper focused on the future of personalised care in medical technology.
Walid also emphasised his intention to continue building this conversation with MedTech World Malta.
“We want to continue with our collaboration with MedTech World in this area as we firmly believe it is the best platform, forum and vehicle to develop and present precision medicine in MedTech.”
As personalised healthcare continues to evolve, this journey reflects the power of the MedTech World ecosystem, where ideas shared on stage can move beyond discussion and into published research that that is helping define the next chapter of healthcare and medical technology devices sector.
As conversations around precision medicine and personalized devices continue to gain momentum, MedTech World remains the platform where ideas move from dialogue to action.
If you are looking to be part of this milestone flagship event, there are several ways to engage in line with your goals:
